Commonwealth Equity Services »

Galectin Therapeutics shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 483k 2.75
2024-06-30 $1.1M 483k 2.26
2024-03-31 $277k 116k 2.39
2023-12-31 $175k 105k 1.66
2023-09-30 $205k 107k 1.92
2023-06-30 $146k 102k 1.44
2023-03-31 $213k 102k 2.10
2022-12-31 $114k 102k 1.12
2022-09-30 $62k 38k 1.62
2022-06-30 $50k 38k 1.31
2022-03-31 $43k 27k 1.60
2021-12-31 $34k 17k 2.01
2021-09-30 $46k 12k 3.86
2019-09-30 $60k 16k 3.67
2019-06-30 $63k 15k 4.13
2019-03-31 $62k 12k 5.09
2018-12-31 $38k 11k 3.40